| abstract |
The present invention relates to polypeptides, epitopes, and antibodies to those epitopes, and more particularly to Group B Streptococcus (GBS) Sip polypeptides, also referred to as Streptococcus agalactiae. Sip polypeptides can be used for the prevention, diagnosis and / or treatment of Streptococcus infections. Also provided by the present invention are pharmaceutical compositions comprising liposomes associated with their antigens, polypeptides, epitopes, antibodies against the epitome, or corresponding DNA fragments. |